{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:51:19Z","timestamp":1781880679107,"version":"3.54.5"},"posted":{"date-parts":[[2026,6,10]]},"group-title":"Immunology","reference-count":158,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1113682"],"award-info":[{"award-number":["OPP1113682"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AI007290"],"award-info":[{"award-number":["AI007290"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HD103571"],"award-info":[{"award-number":["HD103571"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  A broadly neutralizing response to a human immunodeficiency virus (HIV) vaccine is a major goal of the field, yet the determinants of antibody breadth remain poorly defined. Antibody responses to HIV evolve over years of infection, developing unusual features such as high mutation rates in the subset of individuals that acquire breadth. Using single-cell RNA sequencing, single-cell proteomics, and plasma neutralization assays in a longitudinal Kenyan cohort of treatment-naive women living with HIV, we identify systems-level immune correlates of antibody breadth. Broad and narrow neutralizers diverge\n                  <jats:italic>early<\/jats:italic>\n                  in infection along a viral load-driven axis with broad neutralizers exhibiting greater viral loads and CD4 T cell decline; concurrently, NK cells, CD8 T cells, and monocytes, broad neutralizers displayed greater magnitude of immune activation in early infection, followed by exhaustion in late infection. This functional decline may dampen NK cell-mediated pruning of T follicular helper cells, creating a permissive environment for sustained germinal center activity and antibody maturation. Narrow neutralizers, by contrast, maintain functional cellular immunity but lack the antigenic pressure and permissive exhaustive state associated with breadth. Together, these findings suggest that antibody breadth in HIV infection reflects failed viral control rather than a successful antiviral response with implications for vaccination and cure strategies that must balance cellular and humoral immunity.\n                <\/jats:p>","DOI":"10.64898\/2026.06.05.730519","type":"posted-content","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T18:35:16Z","timestamp":1781116516000},"source":"Crossref","is-referenced-by-count":0,"title":["Viral load-driven systemic immune exhaustion is an enabler of antibody breadth in HIV infection"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6479-110X","authenticated-orcid":false,"given":"Izumi","family":"de los Rios Kobara","sequence":"first","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine; Stanford, CA, USA"},{"name":"Stanford Immunology Program, Stanford University School of Medicine; Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0126-5660","authenticated-orcid":false,"given":"Uma M","family":"Mangalanathan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine; Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8026-7036","authenticated-orcid":false,"given":"Soneida","family":"Deline-Caballero","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine; Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5356-6813","authenticated-orcid":false,"given":"Kassandra","family":"Pinedo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine; Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikayla","family":"Stabile","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine; Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1630-1564","authenticated-orcid":false,"given":"Camilo","family":"Espinosa Bernal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine; Stanford, CA, USA"},{"name":"Stanford Immunology Program, Stanford University School of Medicine; Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8296-8645","authenticated-orcid":false,"given":"Hannah L.","family":"Itell","sequence":"additional","affiliation":[{"name":"Division of Human Biology, Fred Hutchinson Cancer Center; Seattle, WA. USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vrasha","family":"Chohan","sequence":"additional","affiliation":[{"name":"Division of Human Biology, Fred Hutchinson Cancer Center; Seattle, WA. USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2574-4201","authenticated-orcid":false,"given":"R. Scott","family":"McClelland","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington; Seattle, WA, USA"},{"name":"Department of Epidemiology, University of Washington; Seattle, WA, USA"},{"name":"Department of Medicine Microbiology and Immunology, University of Nairobi; Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4905-1311","authenticated-orcid":false,"given":"Kishorchandra","family":"Mandaliya","sequence":"additional","affiliation":[{"name":"Coast Provincial General Hospital, Women\u2019s Health Project; Mombasa, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0239-9444","authenticated-orcid":false,"given":"Julie","family":"Overbaugh","sequence":"additional","affiliation":[{"name":"Division of Human Biology, Fred Hutchinson Cancer Center; Seattle, WA. USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6946-7627","authenticated-orcid":false,"given":"Catherine A.","family":"Blish","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine; Stanford, CA, USA"},{"name":"Stanford Immunology Program, Stanford University School of Medicine; Stanford, CA, USA"},{"name":"Chan Zuckerberg Biohub; San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026061906500996000_2026.06.05.730519v2.1","unstructured":"UNAIDS. https:\/\/www.unaids.org\/en."},{"key":"2026061906500996000_2026.06.05.730519v2.2","unstructured":"Schnure, M. et al. HIV Incidence Could Rise by 73% in 30 States if Ryan White Ends: A Simulation Study. in Conference on Retroviruses and Opportunistic Infections (CROI 2026) Denver, CO, USA)."},{"key":"2026061906500996000_2026.06.05.730519v2.3","doi-asserted-by":"publisher","DOI":"10.1038\/417095a"},{"key":"2026061906500996000_2026.06.05.730519v2.4","doi-asserted-by":"publisher","DOI":"10.1038\/35073648"},{"key":"2026061906500996000_2026.06.05.730519v2.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2016.02.012"},{"key":"2026061906500996000_2026.06.05.730519v2.6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41572-023-00452-3","article-title":"HIV infection","volume":"9","year":"2023","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2026061906500996000_2026.06.05.730519v2.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01590-5"},{"key":"2026061906500996000_2026.06.05.730519v2.8","doi-asserted-by":"publisher","DOI":"10.1038\/nri3516"},{"key":"2026061906500996000_2026.06.05.730519v2.9","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-041015-055515"},{"key":"2026061906500996000_2026.06.05.730519v2.10","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00198-11"},{"key":"2026061906500996000_2026.06.05.730519v2.11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005369"},{"key":"2026061906500996000_2026.06.05.730519v2.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.08.012"},{"key":"2026061906500996000_2026.06.05.730519v2.13","doi-asserted-by":"publisher","DOI":"10.1126\/science.1111781"},{"key":"2026061906500996000_2026.06.05.730519v2.14","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aag0851"},{"key":"2026061906500996000_2026.06.05.730519v2.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.033"},{"key":"2026061906500996000_2026.06.05.730519v2.16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20132494"},{"key":"2026061906500996000_2026.06.05.730519v2.17","doi-asserted-by":"publisher","DOI":"10.1038\/nature12744"},{"key":"2026061906500996000_2026.06.05.730519v2.18","doi-asserted-by":"publisher","DOI":"10.1038\/nature12746"},{"key":"2026061906500996000_2026.06.05.730519v2.19","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0235-7"},{"key":"2026061906500996000_2026.06.05.730519v2.20","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.17.8340-8347.2001"},{"key":"2026061906500996000_2026.06.05.730519v2.21","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.5.4009-4018.1999"},{"key":"2026061906500996000_2026.06.05.730519v2.22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.712122"},{"key":"2026061906500996000_2026.06.05.730519v2.23","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1038\/s41591-024-03247-5","article-title":"Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1\/2a trial","volume":"30","year":"2024","journal-title":"Nat. Med"},{"key":"2026061906500996000_2026.06.05.730519v2.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04797-9"},{"key":"2026061906500996000_2026.06.05.730519v2.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0531-2"},{"key":"2026061906500996000_2026.06.05.730519v2.26","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","article-title":"Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption","volume":"375","year":"2016","journal-title":"N. Engl. J. Med"},{"key":"2026061906500996000_2026.06.05.730519v2.27","doi-asserted-by":"publisher","DOI":"10.1038\/nature18929"},{"key":"2026061906500996000_2026.06.05.730519v2.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2019.08.014"},{"key":"2026061906500996000_2026.06.05.730519v2.29","first-page":"107","article-title":"Catch Me If You Can--The Race Between HIV and Neutralizing Antibodies","volume":"17","year":"2015","journal-title":"Aids Rev"},{"key":"2026061906500996000_2026.06.05.730519v2.30","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3390\/vaccines13070690","article-title":"Progress and Recent Developments in HIV Vaccine Research","volume":"13","year":"2025","journal-title":"Vaccines"},{"key":"2026061906500996000_2026.06.05.730519v2.31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf3309"},{"key":"2026061906500996000_2026.06.05.730519v2.32","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01149-09"},{"key":"2026061906500996000_2026.06.05.730519v2.33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/COH.0000000000000552","article-title":"Correlates of broadly neutralizing antibody development","volume":"14","year":"2019","journal-title":"Curr. Opin. HIV AIDS"},{"key":"2026061906500996000_2026.06.05.730519v2.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.08.064"},{"key":"2026061906500996000_2026.06.05.730519v2.35","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0696"},{"key":"2026061906500996000_2026.06.05.730519v2.36","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2249.1990.tb08107.x","article-title":"Natural killer cell-mediated lysis of T cell lines chronically infected with HIV-1","volume":"79","year":"2008","journal-title":"Clin. Exp. Immunol"},{"key":"2026061906500996000_2026.06.05.730519v2.37","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3654::AID-IMMU3654>3.0.CO;2-B"},{"key":"2026061906500996000_2026.06.05.730519v2.38","doi-asserted-by":"crossref","first-page":"113548","DOI":"10.1016\/j.isci.2025.113548","article-title":"NKp30 and NKG2D contribute to natural killer cell-mediated recognition of HIV-infected cells","volume":"28","year":"2025","journal-title":"iScience"},{"key":"2026061906500996000_2026.06.05.730519v2.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2015.07.004"},{"key":"2026061906500996000_2026.06.05.730519v2.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2021.06.004"},{"key":"2026061906500996000_2026.06.05.730519v2.41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41541-017-0027-3","article-title":"Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFN\u03b3 response promoting vaccine immunogenicity","volume":"2","year":"2017","journal-title":"Npj Vaccines"},{"key":"2026061906500996000_2026.06.05.730519v2.42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1621489114"},{"key":"2026061906500996000_2026.06.05.730519v2.43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI75429"},{"key":"2026061906500996000_2026.06.05.730519v2.44","doi-asserted-by":"crossref","unstructured":"Mot, L. D. et al. Transcriptional profiles of adjuvanted hepatitis B vaccines display variable interindividual homogeneity but a shared core signature. Sci Transl Med 12, (2020).","DOI":"10.1126\/scitranslmed.aay8618"},{"key":"2026061906500996000_2026.06.05.730519v2.45","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1016\/j.celrep.2018.08.075","article-title":"Affinity Maturation Is Impaired by Natural Killer Cell Suppression of Germinal Centers","volume":"24","year":"2018","journal-title":"Cell Reports"},{"key":"2026061906500996000_2026.06.05.730519v2.46","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7375"},{"key":"2026061906500996000_2026.06.05.730519v2.47","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2019.0129"},{"key":"2026061906500996000_2026.06.05.730519v2.48","doi-asserted-by":"publisher","DOI":"10.1038\/nature10624"},{"key":"2026061906500996000_2026.06.05.730519v2.49","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.2014010604"},{"key":"2026061906500996000_2026.06.05.730519v2.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2015.10.008"},{"key":"2026061906500996000_2026.06.05.730519v2.51","first-page":"1","article-title":"Interferon-mediated NK cell activation increases cytolytic activity against T follicular helper cells and limits antibody response to SARS-CoV-2","volume":"26","year":"2025","journal-title":"Nat. Immunol"},{"key":"2026061906500996000_2026.06.05.730519v2.52","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0799-2"},{"key":"2026061906500996000_2026.06.05.730519v2.53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12865-022-00523-2","article-title":"Single-cell analysis of immune cell transcriptome during HIV-1 infection and therapy","volume":"23","year":"2022","journal-title":"BMC Immunol"},{"key":"2026061906500996000_2026.06.05.730519v2.54","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1080\/22221751.2020.1826361","article-title":"An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics","volume":"9","year":"2020","journal-title":"Emerg. Microbes Infect"},{"key":"2026061906500996000_2026.06.05.730519v2.55","doi-asserted-by":"crossref","first-page":"RP104856","DOI":"10.7554\/eLife.104856.3","article-title":"Multi-omics single-cell analysis reveals key regulators of HIV-1 persistence and aberrant host immune responses in early infection","volume":"14","year":"2025","journal-title":"eLife"},{"key":"2026061906500996000_2026.06.05.730519v2.56","doi-asserted-by":"crossref","first-page":"105667","DOI":"10.1016\/j.ebiom.2025.105667","article-title":"Single-cell multi-omics profiling uncovers the immune heterogeneity in HIV-infected immunological non-responders","volume":"115","year":"2025","journal-title":"eBioMedicine"},{"key":"2026061906500996000_2026.06.05.730519v2.57","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05225-6"},{"key":"2026061906500996000_2026.06.05.730519v2.58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59833-9"},{"key":"2026061906500996000_2026.06.05.730519v2.59","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12915-022-01382-4","article-title":"Combined protein and transcript single-cell RNA sequencing in human peripheral blood mononuclear cells","volume":"20","year":"2022","journal-title":"BMC Biol"},{"key":"2026061906500996000_2026.06.05.730519v2.60","doi-asserted-by":"crossref","first-page":"113338","DOI":"10.1016\/j.intimp.2024.113338","article-title":"Single-cell sequencing reveals the heterogeneity of immune landscape in drug users with HIV infection","volume":"143","year":"2024","journal-title":"Int. Immunopharmacol"},{"key":"2026061906500996000_2026.06.05.730519v2.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.10.002"},{"key":"2026061906500996000_2026.06.05.730519v2.62","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41467-026-68797-3","article-title":"HIV-seq reveals gene expression differences between HIV-transcribing cells from viremic and suppressed people with HIV","volume":"17","year":"2026","journal-title":"Nat. Commun"},{"key":"2026061906500996000_2026.06.05.730519v2.63","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/COH.0000000000000748","article-title":"CD8+ T-cell responses in HIV controllers: potential implications for novel HIV remission strategies","volume":"17","year":"2022","journal-title":"Curr. Opin. HIV AIDS"},{"key":"2026061906500996000_2026.06.05.730519v2.64","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41591-025-04139-y","article-title":"Innate antiviral and immune functions associated with the HIV reservoir decay after anti-PD-1 therapy","volume":"32","year":"2026","journal-title":"Nat. Med"},{"key":"2026061906500996000_2026.06.05.730519v2.65","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09932-w"},{"key":"2026061906500996000_2026.06.05.730519v2.66","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41590-026-02448-z","article-title":"Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control","volume":"27","year":"2026","journal-title":"Nat. Immunol"},{"key":"2026061906500996000_2026.06.05.730519v2.67","first-page":"e136648","article-title":"TCF-1 regulates HIV-specific CD8+ T cell expansion capacity","volume":"6","year":"2020","journal-title":"JCI Insight"},{"key":"2026061906500996000_2026.06.05.730519v2.68","doi-asserted-by":"crossref","unstructured":"Nguyen, S. et al. Elite control of HIV is associated with distinct functional and transcriptional signatures in lymphoid tissue CD8+ T cells. Sci. Transl. Med. 11, (2019).","DOI":"10.1126\/scitranslmed.aax4077"},{"key":"2026061906500996000_2026.06.05.730519v2.69","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41586-025-09929-5","article-title":"Correlates of HIV-1 control after combination immunotherapy","volume":"650","year":"2026","journal-title":"Nature"},{"key":"2026061906500996000_2026.06.05.730519v2.70","doi-asserted-by":"crossref","first-page":"e3191","DOI":"10.1371\/journal.pone.0003191","article-title":"Genetic Analysis of HIV-1 Subtypes in Nairobi, Kenya","volume":"3","year":"2008","journal-title":"PLoS ONE"},{"key":"2026061906500996000_2026.06.05.730519v2.71","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/aid.1997.13.493","article-title":"Phylogenetic Evaluation of Kenyan HIV Type 1 Isolates","volume":"13","year":"1997","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"2026061906500996000_2026.06.05.730519v2.72","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000442"},{"key":"2026061906500996000_2026.06.05.730519v2.73","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0706737"},{"key":"2026061906500996000_2026.06.05.730519v2.74","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/58.1.19"},{"key":"2026061906500996000_2026.06.05.730519v2.75","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/s41587-023-02033-x","article-title":"Discovery of sparse, reliable omic biomarkers with Stabl","volume":"42","year":"2024","journal-title":"Nat. Biotechnol"},{"key":"2026061906500996000_2026.06.05.730519v2.76","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11904-026-00773-4","article-title":"Cytotoxic CD4 T Cells: Dual Agents in HIV-1 Pathogenesis and Persistence","volume":"23","year":"2026","journal-title":"Curr. HIVAIDS Rep"},{"key":"2026061906500996000_2026.06.05.730519v2.77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002221"},{"key":"2026061906500996000_2026.06.05.730519v2.78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011416"},{"key":"2026061906500996000_2026.06.05.730519v2.79","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1021\/acsomega.2c07933","article-title":"An Overview of Human Anti-HIV- 1 Neutralizing Antibodies against Diverse Epitopes of HIV- 1","volume":"8","year":"2023","journal-title":"ACS Omega"},{"key":"2026061906500996000_2026.06.05.730519v2.80","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500118"},{"key":"2026061906500996000_2026.06.05.730519v2.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.01.010"},{"key":"2026061906500996000_2026.06.05.730519v2.82","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.02.022"},{"key":"2026061906500996000_2026.06.05.730519v2.83","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.10.027"},{"key":"2026061906500996000_2026.06.05.730519v2.84","doi-asserted-by":"crossref","first-page":"e1012223","DOI":"10.1371\/journal.ppat.1012223","article-title":"Natural killer-like B cells are a distinct but infrequent innate immune cell subset modulated by SIV infection of rhesus macaques","volume":"20","year":"2024","journal-title":"PLOS Pathog"},{"key":"2026061906500996000_2026.06.05.730519v2.85","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4421"},{"key":"2026061906500996000_2026.06.05.730519v2.86","doi-asserted-by":"crossref","first-page":"e155601","DOI":"10.1172\/jci.insight.155601","article-title":"Lymph node CXCR5+ NK cells associate with control of chronic SHIV infection","volume":"7","year":"2022","journal-title":"JCI Insight"},{"key":"2026061906500996000_2026.06.05.730519v2.87","first-page":"103794","article-title":"Implications of the accumulation of CXCR5+ NK cells in lymph nodes of HIV-1 infected patients","volume":"75","year":"2021","journal-title":"Ebiomedicine"},{"key":"2026061906500996000_2026.06.05.730519v2.88","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.07.034"},{"key":"2026061906500996000_2026.06.05.730519v2.89","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01884-z"},{"key":"2026061906500996000_2026.06.05.730519v2.90","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01883-0"},{"key":"2026061906500996000_2026.06.05.730519v2.91","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.02.008"},{"key":"2026061906500996000_2026.06.05.730519v2.92","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2789"},{"key":"2026061906500996000_2026.06.05.730519v2.93","doi-asserted-by":"crossref","first-page":"928039","DOI":"10.3389\/fimmu.2022.928039","article-title":"T-Follicular-Like CD8+ T Cell Responses in Chronic HIV Infection Are Associated With Virus Control and Antibody Isotype Switching to IgG","volume":"13","year":"2022","journal-title":"Front. Immunol"},{"key":"2026061906500996000_2026.06.05.730519v2.94","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018017244"},{"key":"2026061906500996000_2026.06.05.730519v2.95","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03704-y"},{"key":"2026061906500996000_2026.06.05.730519v2.96","doi-asserted-by":"crossref","unstructured":"Alshetaiwi, H. et al. Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics. Sci. Immunol. 5, (2020).","DOI":"10.1126\/sciimmunol.aay6017"},{"key":"2026061906500996000_2026.06.05.730519v2.97","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0752-4"},{"key":"2026061906500996000_2026.06.05.730519v2.98","doi-asserted-by":"publisher","DOI":"10.1101\/2023.06.13.544751"},{"key":"2026061906500996000_2026.06.05.730519v2.99","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2009.00867.x"},{"key":"2026061906500996000_2026.06.05.730519v2.100","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01167-5"},{"key":"2026061906500996000_2026.06.05.730519v2.101","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L"},{"key":"2026061906500996000_2026.06.05.730519v2.102","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3389\/fimmu.2019.00964","article-title":"The Emerging Roles of Human Leukocyte Antigen-F in Immune Modulation and Viral Infection","volume":"10","year":"2019","journal-title":"Front. Immunol"},{"key":"2026061906500996000_2026.06.05.730519v2.103","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-017-2023-x"},{"key":"2026061906500996000_2026.06.05.730519v2.104","doi-asserted-by":"crossref","first-page":"1623436","DOI":"10.3389\/fimmu.2025.1623436","article-title":"Targeting myeloid cells to improve cancer immune therapy","volume":"16","year":"2025","journal-title":"Front. Immunol"},{"key":"2026061906500996000_2026.06.05.730519v2.105","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.11.5744"},{"key":"2026061906500996000_2026.06.05.730519v2.106","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.09.006"},{"key":"2026061906500996000_2026.06.05.730519v2.107","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2035"},{"key":"2026061906500996000_2026.06.05.730519v2.108","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00324-2"},{"key":"2026061906500996000_2026.06.05.730519v2.109","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41478-6"},{"key":"2026061906500996000_2026.06.05.730519v2.110","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026173"},{"key":"2026061906500996000_2026.06.05.730519v2.111","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13070564"},{"key":"2026061906500996000_2026.06.05.730519v2.112","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.116.3.817"},{"key":"2026061906500996000_2026.06.05.730519v2.113","doi-asserted-by":"publisher","DOI":"10.4161\/cib.3.6.13495"},{"key":"2026061906500996000_2026.06.05.730519v2.114","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040747"},{"key":"2026061906500996000_2026.06.05.730519v2.115","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.51.32401"},{"key":"2026061906500996000_2026.06.05.730519v2.116","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.04.011"},{"key":"2026061906500996000_2026.06.05.730519v2.117","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0150"},{"key":"2026061906500996000_2026.06.05.730519v2.118","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101313"},{"key":"2026061906500996000_2026.06.05.730519v2.119","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/cells8091082","article-title":"Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners","volume":"8","year":"2019","journal-title":"Cells"},{"key":"2026061906500996000_2026.06.05.730519v2.120","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7318"},{"key":"2026061906500996000_2026.06.05.730519v2.121","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201041178"},{"key":"2026061906500996000_2026.06.05.730519v2.122","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2004.02.002"},{"key":"2026061906500996000_2026.06.05.730519v2.123","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.211423598"},{"key":"2026061906500996000_2026.06.05.730519v2.124","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.9.5205"},{"key":"2026061906500996000_2026.06.05.730519v2.125","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01228"},{"key":"2026061906500996000_2026.06.05.730519v2.126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212443"},{"key":"2026061906500996000_2026.06.05.730519v2.127","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2022.09.019"},{"key":"2026061906500996000_2026.06.05.730519v2.128","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120257"},{"key":"2026061906500996000_2026.06.05.730519v2.129","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.10.022"},{"key":"2026061906500996000_2026.06.05.730519v2.130","doi-asserted-by":"crossref","first-page":"1157537","DOI":"10.3389\/fimmu.2023.1157537","article-title":"Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond","volume":"14","year":"2023","journal-title":"Front. Immunol"},{"key":"2026061906500996000_2026.06.05.730519v2.131","doi-asserted-by":"crossref","first-page":"e170762","DOI":"10.1172\/JCI170762","article-title":"Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target","volume":"133","year":"2023","journal-title":"J. Clin. Investig"},{"key":"2026061906500996000_2026.06.05.730519v2.132","doi-asserted-by":"crossref","first-page":"707198","DOI":"10.3389\/fcell.2021.707198","article-title":"Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy","volume":"09","year":"2021","journal-title":"Front. Cell Dev. Biol"},{"key":"2026061906500996000_2026.06.05.730519v2.133","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2012.01094.x"},{"key":"2026061906500996000_2026.06.05.730519v2.134","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.14033"},{"key":"2026061906500996000_2026.06.05.730519v2.135","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1128\/jvi.68.5.3243-3249.1994","article-title":"Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-kappa B and AP-1 in human T cells in vitro after T-cell receptor stimulation","volume":"68","year":"1994","journal-title":"J. Virol"},{"key":"2026061906500996000_2026.06.05.730519v2.136","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7692"},{"key":"2026061906500996000_2026.06.05.730519v2.137","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13575"},{"key":"2026061906500996000_2026.06.05.730519v2.138","doi-asserted-by":"publisher","DOI":"10.1089\/088922202753747914"},{"key":"2026061906500996000_2026.06.05.730519v2.139","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.71.2.1657-1661.1997"},{"key":"2026061906500996000_2026.06.05.730519v2.140","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01730-06"},{"key":"2026061906500996000_2026.06.05.730519v2.141","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00673-09"},{"key":"2026061906500996000_2026.06.05.730519v2.142","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.4.2855-2864.1998"},{"key":"2026061906500996000_2026.06.05.730519v2.143","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz698"},{"key":"2026061906500996000_2026.06.05.730519v2.144","doi-asserted-by":"publisher","DOI":"10.1093\/bfgp\/elac044"},{"key":"2026061906500996000_2026.06.05.730519v2.145","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btv359"},{"key":"2026061906500996000_2026.06.05.730519v2.146","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt382"},{"key":"2026061906500996000_2026.06.05.730519v2.147","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adr1032"},{"key":"2026061906500996000_2026.06.05.730519v2.148","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28791-2"},{"key":"2026061906500996000_2026.06.05.730519v2.149","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2015.020"},{"key":"2026061906500996000_2026.06.05.730519v2.150","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/cyto.a.22271","article-title":"Normalization of mass cytometry data with bead standards","volume":"83A","year":"2013","journal-title":"Cytom. Part A"},{"key":"2026061906500996000_2026.06.05.730519v2.151","unstructured":"Biotools, S. Approach to Bivariate Analysis of Data Acquired Using the Maxpar Direct Immune Profiling Assay. Preprint at (2022)."},{"key":"2026061906500996000_2026.06.05.730519v2.152","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELL.2021.04.048"},{"key":"2026061906500996000_2026.06.05.730519v2.153","unstructured":"Heimberg, G. et al. SCimilarity Models (1.0). (Zenodo)."},{"key":"2026061906500996000_2026.06.05.730519v2.154","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41586-024-08411-y","article-title":"A cell atlas foundation model for scalable search of similar human cells","volume":"638","year":"2025","journal-title":"Nature"},{"key":"2026061906500996000_2026.06.05.730519v2.155","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0276-y"},{"key":"2026061906500996000_2026.06.05.730519v2.156","unstructured":"R: A Language and Environment for Statistical Computing. (R Foundation for Statistical Computing, Vienna, Austria, 2021)."},{"key":"2026061906500996000_2026.06.05.730519v2.157","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1002\/imt2.43","article-title":"Complex heatmap visualization","volume":"1","year":"2022","journal-title":"iMeta"},{"key":"2026061906500996000_2026.06.05.730519v2.158","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw313"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.06.05.730519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:50:28Z","timestamp":1781877028000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.06.05.730519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":158,"URL":"https:\/\/doi.org\/10.64898\/2026.06.05.730519","relation":{},"subject":[],"published":{"date-parts":[[2026,6,10]]},"subtype":"preprint"}}